Vajkoczy, P <br/><br/>
Measuring VEGF-Flk-1 activity and consequences of VEGF-Flk-1 targeting in vivo using intravital microscopy: clinical applications.  [electronic resource] 

 -  The oncologist  2000 
 - 16-9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1083-7159 
<br/><br/><label>Standard No.: </label>10.1634/theoncologist.5-suppl_1-16  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Analysis of Variance<br/>Angiogenesis Inhibitors--therapeutic use<br/>Animals<br/>Disease Models, Animal<br/>Endothelial Growth Factors--antagonists & inhibitors<br/>Enzyme Inhibitors--administration & dosage<br/>Glioblastoma--blood supply<br/>Indoles--administration & dosage<br/>Lymphokines--antagonists & inhibitors<br/>Male<br/>Mice<br/>Mice, Nude<br/>Microcirculation--drug effects<br/>Microscopy, Fluorescence<br/>Microscopy, Video<br/>Neoplasm Transplantation<br/>Neovascularization, Pathologic--drug therapy<br/>Protein Isoforms--antagonists & inhibitors<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Pyrroles--administration & dosage<br/>Rats<br/>Receptor Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Receptors, Growth Factor--antagonists & inhibitors<br/>Receptors, Mitogen--antagonists & inhibitors<br/>Receptors, Vascular Endothelial Growth Factor<br/>Signal Transduction--drug effects<br/>Skin Neoplasms--blood supply<br/>Vascular Endothelial Growth Factor A<br/>Vascular Endothelial Growth Factors